Clinical Trial Update: Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532 [Phase 1]

View source ↗

Summary

A Phase 1 study completed to evaluate how renal impairment affects the pharmacokinetics of PF-04991532 in individuals with Type 2 diabetes mellitus and in healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-04991532 (PF-04991532)

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus, Healthy | Phase 1 | Status: COMPLETED